Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 64 | 2024 | 728 | 16.800 |
Why?
|
| Quality of Life | 50 | 2023 | 946 | 9.750 |
Why?
|
| Spirituality | 16 | 2024 | 37 | 5.560 |
Why?
|
| Adaptation, Psychological | 22 | 2022 | 138 | 3.900 |
Why?
|
| Young Adult | 55 | 2024 | 2665 | 3.420 |
Why?
|
| Psychometrics | 15 | 2022 | 137 | 3.120 |
Why?
|
| Adolescent | 52 | 2024 | 3568 | 2.880 |
Why?
|
| Religion and Medicine | 6 | 2016 | 19 | 2.670 |
Why?
|
| Survivors | 17 | 2023 | 163 | 2.630 |
Why?
|
| Stress, Psychological | 16 | 2024 | 222 | 2.450 |
Why?
|
| Humans | 96 | 2024 | 32082 | 2.070 |
Why?
|
| Self Efficacy | 4 | 2019 | 78 | 2.000 |
Why?
|
| Resilience, Psychological | 3 | 2024 | 18 | 1.990 |
Why?
|
| Social Support | 9 | 2024 | 182 | 1.990 |
Why?
|
| Adult | 52 | 2024 | 9375 | 1.880 |
Why?
|
| Female | 62 | 2024 | 19999 | 1.450 |
Why?
|
| Health Status | 6 | 2018 | 400 | 1.400 |
Why?
|
| Male | 51 | 2024 | 19202 | 1.380 |
Why?
|
| Mental Health | 7 | 2023 | 119 | 1.370 |
Why?
|
| Caregivers | 4 | 2024 | 114 | 1.340 |
Why?
|
| Medical Oncology | 4 | 2023 | 86 | 1.330 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2018 | 27 | 1.290 |
Why?
|
| Emotions | 6 | 2024 | 58 | 1.170 |
Why?
|
| Personal Satisfaction | 5 | 2018 | 28 | 1.010 |
Why?
|
| Telemedicine | 2 | 2023 | 102 | 0.960 |
Why?
|
| Patients | 2 | 2016 | 46 | 0.940 |
Why?
|
| Middle Aged | 30 | 2020 | 11834 | 0.900 |
Why?
|
| Chronic Disease | 6 | 2023 | 406 | 0.880 |
Why?
|
| Reproducibility of Results | 10 | 2022 | 765 | 0.860 |
Why?
|
| Fatigue | 5 | 2019 | 85 | 0.850 |
Why?
|
| Psychology | 3 | 2019 | 24 | 0.820 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 299 | 0.740 |
Why?
|
| Biomedical Research | 2 | 2024 | 156 | 0.700 |
Why?
|
| Colorectal Neoplasms | 3 | 2014 | 215 | 0.670 |
Why?
|
| United States | 15 | 2024 | 3975 | 0.660 |
Why?
|
| Cognition | 6 | 2015 | 556 | 0.640 |
Why?
|
| Income | 1 | 2019 | 63 | 0.640 |
Why?
|
| Affective Symptoms | 2 | 2015 | 16 | 0.560 |
Why?
|
| Grief | 1 | 2016 | 1 | 0.560 |
Why?
|
| Attitude to Death | 1 | 2016 | 2 | 0.560 |
Why?
|
| Bereavement | 1 | 2016 | 2 | 0.560 |
Why?
|
| Depression | 6 | 2024 | 445 | 0.560 |
Why?
|
| Aged | 19 | 2023 | 10308 | 0.550 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 606 | 0.540 |
Why?
|
| Infertility | 1 | 2016 | 19 | 0.530 |
Why?
|
| Religion and Psychology | 3 | 2016 | 7 | 0.510 |
Why?
|
| Guideline Adherence | 1 | 2016 | 120 | 0.500 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 1542 | 0.490 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 97 | 0.490 |
Why?
|
| Anorexia | 1 | 2014 | 5 | 0.490 |
Why?
|
| Cachexia | 1 | 2014 | 7 | 0.490 |
Why?
|
| Continental Population Groups | 1 | 2016 | 237 | 0.490 |
Why?
|
| Health Status Indicators | 1 | 2014 | 73 | 0.470 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 3990 | 0.470 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2022 | 510 | 0.470 |
Why?
|
| Factor Analysis, Statistical | 6 | 2019 | 77 | 0.460 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 101 | 0.450 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 271 | 0.450 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 407 | 0.450 |
Why?
|
| Ethnic Groups | 1 | 2016 | 476 | 0.450 |
Why?
|
| Vomiting | 2 | 2014 | 24 | 0.430 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 47 | 0.430 |
Why?
|
| Nausea | 2 | 2014 | 53 | 0.430 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 39 | 0.430 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 172 | 0.420 |
Why?
|
| Survival Rate | 5 | 2019 | 876 | 0.410 |
Why?
|
| Research Design | 3 | 2023 | 315 | 0.400 |
Why?
|
| Social Isolation | 3 | 2024 | 45 | 0.380 |
Why?
|
| Perception | 1 | 2012 | 101 | 0.380 |
Why?
|
| Health Personnel | 1 | 2012 | 121 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 414 | 0.360 |
Why?
|
| Ovarian Neoplasms | 3 | 2006 | 96 | 0.340 |
Why?
|
| Mental Health Services | 3 | 2024 | 31 | 0.340 |
Why?
|
| Socioeconomic Factors | 5 | 2023 | 429 | 0.330 |
Why?
|
| Child | 7 | 2023 | 2439 | 0.320 |
Why?
|
| Feasibility Studies | 4 | 2023 | 294 | 0.320 |
Why?
|
| Self Concept | 2 | 2023 | 43 | 0.310 |
Why?
|
| Mass Screening | 3 | 2006 | 263 | 0.300 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 765 | 0.300 |
Why?
|
| Kidney Neoplasms | 2 | 2023 | 201 | 0.300 |
Why?
|
| Anxiety | 3 | 2024 | 191 | 0.280 |
Why?
|
| Behavior | 2 | 2015 | 30 | 0.260 |
Why?
|
| Communication | 3 | 2023 | 142 | 0.250 |
Why?
|
| Behavioral Medicine | 2 | 2016 | 6 | 0.250 |
Why?
|
| Attitude | 1 | 2005 | 40 | 0.250 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2022 | 30 | 0.250 |
Why?
|
| Cohort Studies | 5 | 2024 | 1816 | 0.240 |
Why?
|
| Cancer Care Facilities | 2 | 2017 | 10 | 0.230 |
Why?
|
| Health Facilities | 1 | 2024 | 10 | 0.230 |
Why?
|
| Financing, Government | 1 | 2024 | 11 | 0.230 |
Why?
|
| Interpersonal Relations | 2 | 2015 | 57 | 0.230 |
Why?
|
| Research Support as Topic | 1 | 2024 | 26 | 0.230 |
Why?
|
| Empirical Research | 1 | 2023 | 9 | 0.220 |
Why?
|
| Social Conditions | 1 | 2022 | 3 | 0.220 |
Why?
|
| Minority Groups | 1 | 2023 | 83 | 0.210 |
Why?
|
| Sarcoma | 1 | 2023 | 73 | 0.210 |
Why?
|
| Registries | 2 | 2017 | 298 | 0.210 |
Why?
|
| Prevalence | 3 | 2015 | 989 | 0.200 |
Why?
|
| Religion | 3 | 2016 | 32 | 0.190 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 75 | 0.190 |
Why?
|
| Health Expenditures | 1 | 2021 | 65 | 0.190 |
Why?
|
| Program Evaluation | 1 | 2021 | 185 | 0.190 |
Why?
|
| Decision Making | 1 | 2023 | 194 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 169 | 0.180 |
Why?
|
| Motivation | 1 | 2021 | 113 | 0.180 |
Why?
|
| Meditation | 1 | 2020 | 22 | 0.170 |
Why?
|
| Social Change | 1 | 2019 | 3 | 0.170 |
Why?
|
| Psychotherapy | 1 | 2019 | 19 | 0.170 |
Why?
|
| Calibration | 1 | 2019 | 28 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3304 | 0.170 |
Why?
|
| Focus Groups | 1 | 2019 | 118 | 0.160 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 99 | 0.160 |
Why?
|
| Comprehension | 1 | 2018 | 19 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2019 | 175 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2017 | 354 | 0.150 |
Why?
|
| Electronic Health Records | 2 | 2017 | 164 | 0.150 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 19 | 0.140 |
Why?
|
| Chicago | 1 | 2016 | 10 | 0.140 |
Why?
|
| Health Behavior | 3 | 2009 | 236 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 58 | 0.140 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 47 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 2263 | 0.130 |
Why?
|
| Dementia | 1 | 2019 | 253 | 0.130 |
Why?
|
| Affect | 2 | 2013 | 70 | 0.130 |
Why?
|
| Hypertension | 1 | 2023 | 961 | 0.130 |
Why?
|
| Fertility | 1 | 2016 | 31 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 36 | 0.130 |
Why?
|
| Spiritual Therapies | 1 | 2015 | 2 | 0.130 |
Why?
|
| Indoles | 1 | 2016 | 56 | 0.130 |
Why?
|
| Documentation | 1 | 2016 | 46 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2016 | 67 | 0.130 |
Why?
|
| Pyrroles | 1 | 2016 | 55 | 0.130 |
Why?
|
| Students | 2 | 2009 | 178 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2016 | 65 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1128 | 0.130 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2015 | 36 | 0.120 |
Why?
|
| Prognosis | 1 | 2019 | 1496 | 0.120 |
Why?
|
| Appetite Stimulants | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptors, Ghrelin | 1 | 2014 | 2 | 0.120 |
Why?
|
| Hydrazines | 1 | 2014 | 4 | 0.120 |
Why?
|
| Palliative Care | 1 | 2015 | 52 | 0.120 |
Why?
|
| Placebos | 1 | 2014 | 63 | 0.120 |
Why?
|
| Appetite | 1 | 2014 | 22 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2014 | 44 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 472 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 881 | 0.120 |
Why?
|
| Whole-Body Irradiation | 1 | 2015 | 53 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 114 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2015 | 58 | 0.120 |
Why?
|
| Primary Health Care | 1 | 2017 | 227 | 0.120 |
Why?
|
| Hand Strength | 1 | 2014 | 101 | 0.120 |
Why?
|
| Sex Factors | 1 | 2016 | 667 | 0.110 |
Why?
|
| Sickness Impact Profile | 2 | 2011 | 35 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2023 | 3505 | 0.110 |
Why?
|
| Employment | 1 | 2013 | 48 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2012 | 21 | 0.110 |
Why?
|
| Regression Analysis | 2 | 2014 | 292 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2015 | 1267 | 0.100 |
Why?
|
| Risk Factors | 4 | 2023 | 3880 | 0.100 |
Why?
|
| Educational Status | 1 | 2013 | 181 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2014 | 2282 | 0.100 |
Why?
|
| Antiemetics | 1 | 2012 | 6 | 0.100 |
Why?
|
| Social Desirability | 2 | 2009 | 12 | 0.100 |
Why?
|
| Pediatrics | 1 | 2013 | 155 | 0.100 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2011 | 70 | 0.090 |
Why?
|
| Weight Loss | 1 | 2014 | 480 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2023 | 895 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2020 | 547 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 184 | 0.090 |
Why?
|
| Kentucky | 1 | 2009 | 15 | 0.080 |
Why?
|
| Universities | 1 | 2009 | 150 | 0.080 |
Why?
|
| Psychological Theory | 1 | 2007 | 6 | 0.070 |
Why?
|
| Sexual Behavior | 2 | 2023 | 120 | 0.070 |
Why?
|
| Parents | 2 | 2021 | 147 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2006 | 378 | 0.060 |
Why?
|
| Information Systems | 2 | 2015 | 10 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 770 | 0.060 |
Why?
|
| Endosonography | 1 | 2004 | 56 | 0.060 |
Why?
|
| Vagina | 1 | 2004 | 59 | 0.060 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 34 | 0.060 |
Why?
|
| Gender Identity | 1 | 2023 | 27 | 0.060 |
Why?
|
| Bisexuality | 1 | 2023 | 30 | 0.060 |
Why?
|
| Data Collection | 1 | 2024 | 181 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 90 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 112 | 0.050 |
Why?
|
| Spouses | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2022 | 35 | 0.050 |
Why?
|
| Substance-Related Disorders | 2 | 2016 | 128 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 85 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 245 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 160 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 46 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 1187 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 348 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2020 | 34 | 0.040 |
Why?
|
| Education, Distance | 1 | 2019 | 19 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 126 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 220 | 0.030 |
Why?
|
| Exercise | 1 | 2021 | 672 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 142 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 54 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 10 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 25 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 21 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 15 | 0.030 |
Why?
|
| American Cancer Society | 1 | 2015 | 3 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 317 | 0.030 |
Why?
|
| Internet | 1 | 2016 | 197 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 81 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 103 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 76 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 246 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 166 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 124 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 98 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 30 | 0.030 |
Why?
|
| Happiness | 1 | 2013 | 3 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 322 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 188 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 434 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 507 | 0.030 |
Why?
|
| Pain | 1 | 2014 | 287 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1199 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 266 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 462 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 110 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 7 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 58 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 78 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 159 | 0.020 |
Why?
|
| Mastectomy | 1 | 2005 | 64 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2005 | 83 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 206 | 0.020 |
Why?
|
| Elder Abuse | 1 | 2004 | 1 | 0.020 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 4 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 190 | 0.020 |
Why?
|
| Sick Role | 1 | 2004 | 7 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2004 | 62 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2006 | 166 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 447 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 7510 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 873 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 1427 | 0.010 |
Why?
|